Rhythm Pharmaceuticals (RYTM)
(Delayed Data from NSDQ)
$29.08 USD
-1.39 (-4.56%)
Updated Jan 27, 2023 04:00 PM ET
After-Market: $29.09 +0.01 (0.03%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
03/07/2023
Time: -- |
12/2022 | $-0.82 | 6.28% |
Earnings Summary
For their last quarter, Rhythm Pharmaceuticals (RYTM) reported earnings of -$0.79 per share, beating the Zacks Consensus Estimate of $-1.01 per share. This reflects a positive earnings surprise of 21.78%. Look out for RYTM's next earnings release expected on March 07, 2023. For the next earning release, we expect the company to report earnings of -$0.82 per share, reflecting a year-over-year increase of 3.53%.
Earnings History
Price & Consensus
Zacks News for RYTM
Earnings Preview: Solid Biosciences Inc. (SLDB) Q3 Earnings Expected to Decline
RYTM: What are Zacks experts saying now?
Zacks Private Portfolio Services